Cafirate Oral Solution 3 ml

Babies: Safe if prescribed by your doctor. Lactating mother: Cafirate solution must be used with caution during breastfeeding. Pregnancy: Consult your doctor before using this medication in pregnancy.
Limited human and animal data suggest that this drug may cause may harmful effects on the developing baby. Alcohol: Avoid alcohol while taking this medication. Driving: Cafirate solution may cause side effects like sleepiness, dizziness, and reduced alertness.
Do not drive if any symptoms affect your ability to drive. Kidney: Consult your doctor before using this medication in patients with kidney disease because limited information is available. Liver: Consult your doctor before using this medication in patients with liver disease because limited information is available..

Restlessness Headache Dizziness Increased heart rate Insomnia (difficulty in breathing).

Cafirate solution is a cns stimulant. It works by blocking the action of certain natural substances, which leads to stimulation of the brain and respiratory system in premature babies.
Thus, it decreases breathing problems, and the baby can breathe easily..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Cafirate solution is used in the treatment of apnea in premature babies. • Inform your doctor if you are pregnant or breastfeeding.
• Avoid coffee or cafirate-containing products during breastfeeding because they may pass into breast milk..

Contraindications: • Cafirate + Riociguat: Concurrent use may result in an increased risk of hypotension • Cafirate + Viloxazine: Concurrent use may result in increased exposure to cafirate and risk of adverse events Major: • Cafirate + Capmatinib: Concurrent use may result in an increased risk f adverse reactions • Cafirate + Givosiran: Concurrent use may result in increased plasma concentration of cafirate • Cafirate + Iobenguane: Concurrent use may result in reduced efficacy.